Seeing Is Believing
KRYS is currently covered by 3 analysts with an average price target of $219. This is a potential upside of $35.64 (19.44%) from yesterday's end of day stock price of $183.36.
Krystal Biotech's activity chart (see below) currently has 87 price targets and 53 ratings on display. The stock rating distribution of KRYS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 322.25 days.
Highest price target for KRYS is $220, Lowest price target is $166, average price target is $194.25.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 05-Aug-2025. First documented stock forecast 17-Oct-2017.
Currently out of the existing stock ratings of KRYS, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$166
$-1.82 (-1.08%)
$215
2 months ago
(05-Aug-2025)
2/5 (40%)
$28.65 (20.86%)
94
Buy
$202
$18.64 (10.17%)
$130
4 months 29 days ago
(06-May-2025)
4/5 (80%)
$65.2 (47.66%)
352
Buy
$189
$5.64 (3.08%)
$83
4 months 29 days ago
(06-May-2025)
4/5 (80%)
$52.2 (38.16%)
376
Buy
$220
$36.64 (19.98%)
$168
7 months 17 days ago
(18-Feb-2025)
1/2 (50%)
$43.83 (24.88%)
204
Buy
$220
$36.64 (19.98%)
$145
1 years 25 days ago
(10-Sep-2024)
1/2 (50%)
$21.21 (10.67%)
279
What is KRYS (Krystal Biotech) average time for price targets to be met?
Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?
Which analyst has the most public recommendations on KRYS (Krystal Biotech)?
Which analyst is the currently most bullish on KRYS (Krystal Biotech)?
Which analyst is the currently most reserved on KRYS (Krystal Biotech)?